DEK

Across TCGA pan-cancer cohorts, DEK mass-spec protein differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of DEK’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where DEK mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types DEK is over-expressed in tumor, although a few such as PDAC show the opposite, repressed pattern.

COAD, LSCC, and HNSC are the cancer types where DEK tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in DEK mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Female	II,III,IV	+0.530	<.001	11	view →
LSCC	Male	II,III,IV	+0.467	<.001	8	view →
HNSC	Male	IV	+0.364	<.001	8	view →
LUAD	Male	All	+0.334	<.001	8	view →
CCRCC	Male	III,IV	+0.270	<.001	7	view →
PDAC	Female	All	−0.200	.005	3	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

DEK–COAD

Open the COAD breakdown →